Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
Smad3 | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 5 | 0 | 0 | 5 |
microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 3 | 0 | 5 |
Carbonic anhydrase 2 | 0 | 3 | 0 | 5 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 0 | 1 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
thioredoxin reductase | 3 | 0 | 0 | 3 |
phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
GLS protein | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
flap endonuclease 1 | 2 | 0 | 0 | 2 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
Cytochrome P450 3A4 | 0 | 1 | 0 | 2 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 16 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 21 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Luciferase | 2 | 0 | 0 | 2 |
acetylcholinesterase | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
TDP1 protein | 3 | 0 | 0 | 3 |
GLI family zinc finger 3 | 3 | 0 | 0 | 3 |
AR protein | 4 | 0 | 0 | 4 |
estrogen receptor 2 (ER beta) | 2 | 0 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 3 | 2 | 0 | 0 | 2 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
glucocorticoid receptor [Homo sapiens] | 2 | 0 | 0 | 2 |
estrogen-related nuclear receptor alpha | 3 | 0 | 0 | 3 |
estrogen nuclear receptor alpha | 6 | 0 | 0 | 6 |
peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
activating transcription factor 6 | 3 | 0 | 0 | 3 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 4 | 0 | 0 | 4 |
Histone H2A.x | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 3 | 0 | 0 | 3 |
B2 bradykinin receptor | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
Dihydrofolate reductase | 0 | 0 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chymotrypsinogen A | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Cellular tumor antigen p53 | 1 | 0 | 0 | 1 |
Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 0 | 1 |
Beta-galactosidase | 0 | 2 | 0 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 3 | 0 | 3 |
Glutamate receptor 2 | 2 | 0 | 0 | 2 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 0 | 2 | 0 | 2 |
PH domain leucine-rich repeat-containing protein phosphatase 2 | 0 | 1 | 0 | 1 |
Chymotrypsin-C | 0 | 1 | 0 | 1 |
retinoic acid nuclear receptor alpha variant 1 | 3 | 0 | 0 | 3 |
thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 3 | 0 | 0 | 3 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
EWS/FLI fusion protein | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
USP1 protein, partial | 1 | 0 | 0 | 1 |
IDH1 | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
Lipopolysaccharide heptosyltransferase 1 | 0 | 1 | 0 | 1 |
PA-I galactophilic lectin | 0 | 0 | 1 | 1 |
Jacalin | 0 | 0 | 1 | 1 |
Chain A, Glutamine Binding Protein | 0 | 0 | 1 | 1 |
15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
arylsulfatase A | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
Amino acid transporter | 0 | 1 | 0 | 1 |
progesterone receptor | 2 | 0 | 0 | 2 |
retinoid X nuclear receptor alpha | 1 | 0 | 0 | 1 |
pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
SMAD family member 2 | 1 | 0 | 0 | 1 |
SMAD family member 3 | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
geminin | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 4 | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
Spike glycoprotein | 2 | 0 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 2 | 0 | 2 |
Chain A, CHORISMATE MUTASE | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-tRNA SYNTHETASE | 0 | 0 | 1 | 1 |
Polyphenol oxidase 2 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 0 | 0 | 1 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 0 | 0 | 1 |
Adenosine receptor A1 | 0 | 0 | 0 | 1 |
Adenosine receptor A2a | 0 | 0 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
SLC16A10 protein | 0 | 0 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Tubulin--tyrosine ligase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
Taste receptor type 2 member 14 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
Guanine deaminase | 0 | 1 | 0 | 1 |
P2Y purinoceptor 2 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 6 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 14 | 0 | 0 | 1 | 1 |
glp-1 receptor, partial | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
G | 1 | 0 | 0 | 1 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Interferon beta | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Glycoprotein | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 1 | 10 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 2 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 2 | 1 | 4 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
Ataxin-2 | 1 | 0 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 1 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |